Quality of Life in Women with Breast Cancer
Author Information
Author(s): Joly F, Espié M, Marty M, Héron J-F, Henry-Amar M
Primary Institution: Service de Recherche Clinique, Service d’Oncologie, Centre François Baclesse
Hypothesis
Does adjuvant chemotherapy impact the long-term quality of life in premenopausal women with localized breast cancer?
Conclusion
Adjuvant CMF chemotherapy does not appear to impair the quality of life or social and professional life in premenopausal women treated for localized breast cancer.
Supporting Evidence
- 119 out of 179 patients participated in the study.
- 68% of participants had conservative surgery.
- 65% of patients received CMF chemotherapy.
- 75% of patients underwent irradiation regardless of chemotherapy.
Takeaway
This study looked at how women felt years after treatment for breast cancer, and found that chemotherapy didn't make their lives worse.
Methodology
Two self-administered questionnaires were mailed to participants to evaluate their quality of life.
Limitations
The study may not represent all women with breast cancer as it focused on a specific group.
Participant Demographics
Participants were premenopausal women, node-negative, with a mean age of 54 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website